Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Defining the Therapeutic Ceiling of Endovascular Thrombectomy in Large-Core Stroke: Beyond the Limits of ASPECTS.

Stroke·2026

Same author

Comprehensive Prestroke Risk Factor Control and Functional Outcomes After Acute Ischemic Stroke.

Journal of the American Heart Association·2026

Same author

Early-onset hereditary spastic paraplegia type 56 (SPG56): clinical-molecular correlations and functional validation of CYP2U1 variants.

BMC medical genomics·2026

Same author

Occurrence of cerebral infarction, a threshold-sensitive nonlinear process: Lessons from a new stroke model, NAIM.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026

Same author

Real-world effectiveness of thrombectomy for basilar artery occlusion: lessons beyond the ATTENTION and BAOCHE trials.

European stroke journal·2026

Same author

EnzymeMiner 2.0: advancing automated enzyme discovery with expansive sequence mining and smart property analysis.

Nucleic acids research·2026

Search research articles

Related Experiment Video

Updated: Nov 17, 2025

Prehospital Thrombolysis: A Manual from Berlin

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Development and Testing of Thrombolytics in Stroke.

Dmitri Nikitin^1,2, Seungbum Choi³, Jan Mican^1,2,4

¹International Centre for Clinical Research, St. Anne's Hospital, Brno, Czech Republic.

Journal of Stroke

|February 18, 2021

Summary

This summary is machine-generated.

Mechanical thrombectomy has limitations for ischemic stroke treatment. Thrombolytic agents remain crucial for hyperacute stroke, but new drugs are needed to improve efficacy and reduce bleeding complications.

Keywords:

Protein engineering Stroke Thrombolytic therapy Tissue plasminogen activator

More Related Videos

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

Related Experiment Videos

Last Updated: Nov 17, 2025

Prehospital Thrombolysis: A Manual from Berlin

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

Area of Science:

Neuroscience
Cardiovascular Medicine
Pharmacology

Background:

Mechanical thrombectomy for ischemic stroke has limited global access and cannot treat all cerebral artery occlusions.
Current thrombolytic agents, while vital for hyperacute stroke, exhibit suboptimal efficacy and carry risks of hemorrhagic complications.
Developing improved thrombolytic therapies is essential to address the unmet needs in stroke treatment.

Purpose of the Study:

To review current thrombolytic agents for ischemic stroke.
To explore strategies for developing novel clot-dissolving substances.
To discuss methods for assessing thrombolytic efficacy.

Main Methods:

Literature review of basic and clinical research on thrombolytic therapy.
Analysis of the characteristics of ideal thrombolytic agents compared to alteplase.
Examination of in vitro and in vivo methods for evaluating thrombolytic efficacy.

Main Results:

Mechanical thrombectomy is not universally accessible or suitable for all ischemic stroke cases.
Thrombolytic therapy remains a critical treatment for hyperacute ischemic stroke.
There is a clear need for improved thrombolytic drugs with enhanced efficacy, safety, and pharmacokinetic profiles.

Conclusions:

Despite advances, mechanical thrombectomy has limitations for ischemic stroke treatment.
Thrombolytic agents are indispensable for hyperacute ischemic stroke, necessitating the development of superior alternatives.
Future thrombolytics should aim for faster reperfusion, reduced re-occlusion, increased fibrin specificity, prolonged circulation, and lower immunogenicity.